140 related articles for article (PubMed ID: 16055783)
21. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
Kozlowski LT
Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
[TBL] [Abstract][Full Text] [Related]
22. The effectiveness of Mint Snuff as an oral substitute in smokeless tobacco cessation.
Zavela KJ; Harrison LR; Smith CA; Smith MR; Manske KA
J Colo Dent Assoc; 1995 Jan; 73(3):26-7. PubMed ID: 9470590
[No Abstract] [Full Text] [Related]
23. [Smoking cessation].
Patja K; Rouhos A
Duodecim; 2004; 120(19):2347-52. PubMed ID: 15565988
[No Abstract] [Full Text] [Related]
24. Tobacco harm reduction: how rational public policy could transform a pandemic.
Sweanor D; Alcabes P; Drucker E
Int J Drug Policy; 2007 Mar; 18(2):70-4. PubMed ID: 17689347
[TBL] [Abstract][Full Text] [Related]
25. Epidemiologic perspectives on smokeless tobacco marketing and population harm.
Tomar SL
Am J Prev Med; 2007 Dec; 33(6 Suppl):S387-97. PubMed ID: 18021914
[TBL] [Abstract][Full Text] [Related]
26. Dependence potential of nicotine replacement treatments: effects of product type, patient characteristics, and cost to user.
Hajek P; McRobbie H; Gillison F
Prev Med; 2007 Mar; 44(3):230-4. PubMed ID: 17207524
[TBL] [Abstract][Full Text] [Related]
27. What's new in Nicotine & Tobacco Research?
Hébert R
Nicotine Tob Res; 2008 Feb; 10(2):247-52. PubMed ID: 18236289
[No Abstract] [Full Text] [Related]
28. What's new in Nicotine & Tobacco Research?
Hébert R
Nicotine Tob Res; 2009 Sep; 11(9):1021-4. PubMed ID: 19671878
[No Abstract] [Full Text] [Related]
29. What's new in Nicotine & Tobacco Research?
Hebert R
Nicotine Tob Res; 2008 Aug; 10(8):1269-75. PubMed ID: 18686173
[No Abstract] [Full Text] [Related]
30. Tobacco control policies and the concurrent use of smokeless tobacco and cigarettes among men, 1992-2002.
Mumford EA; Levy DT; Gitchell JG; Blackman KO
Nicotine Tob Res; 2005 Dec; 7(6):891-900. PubMed ID: 16298724
[TBL] [Abstract][Full Text] [Related]
31. What's new in nicotine & tobacco research?
Hébert R
Nicotine Tob Res; 2008 Sep; 10(9):1429-32. PubMed ID: 19023833
[No Abstract] [Full Text] [Related]
32. Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.
Mendoza-Baumgart MI; Tulunay OE; Hecht SS; Zhang Y; Murphy S; Le C; Jensen J; Hatsukami DK
Nicotine Tob Res; 2007 Dec; 9(12):1309-23. PubMed ID: 18058349
[TBL] [Abstract][Full Text] [Related]
33. What's new in nicotine & tobacco research?
Hébert R
Nicotine Tob Res; 2006 Dec; 8 Suppl 1():S1-6. PubMed ID: 17491164
[No Abstract] [Full Text] [Related]
34. Smoking during the night: prevalence and smoker characteristics.
Scharf DM; Dunbar MS; Shiffman S
Nicotine Tob Res; 2008 Jan; 10(1):167-78. PubMed ID: 18188757
[TBL] [Abstract][Full Text] [Related]
35. What's new in nicotine & tobacco research?
Hébert R
Nicotine Tob Res; 2008 Mar; 10(3):399-405. PubMed ID: 18324556
[No Abstract] [Full Text] [Related]
36. What's new in nicotine & tobacco research?
Hebert R
Nicotine Tob Res; 2008 Jun; 10(6):943-50. PubMed ID: 18584457
[No Abstract] [Full Text] [Related]
37. Smoking cessation in the spine surgeon's office: a review.
Rechtine GR; Rechtine JC; Bolesta MJ
J Spinal Disord; 1999 Dec; 12(6):477-81. PubMed ID: 10598988
[TBL] [Abstract][Full Text] [Related]
38. Smokeless tobacco: an emerging addiction.
Ebbert JO; Carr AB; Dale LC
Med Clin North Am; 2004 Nov; 88(6):1593-605. PubMed ID: 15464115
[TBL] [Abstract][Full Text] [Related]
39. Youth tobacco use and control efforts in West Virginia.
Lee D; Purkey M
W V Med J; 2001; 97(1):56-9. PubMed ID: 11257842
[No Abstract] [Full Text] [Related]
40. Smokers' preferences for medicinal nicotine vs smokeless tobacco.
Shiffman S; Gitchell J; Rohay JM; Hellebusch SJ; Kemper KE
Am J Health Behav; 2007; 31(5):462-72. PubMed ID: 17555377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
